Changes in IGFBP-2 levels are associated with various physiological and pathological states, such as exercise, pregnancy, aging, hormones, diabetes, obesity, insulin resistance and tumours [24–26]. Here, IGFBP2 is linked to obesity due to melanocortin 4 receptor deficiency.